secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2021-11-04T23:59:59+00:00
Accession:  0001437749-21-025336
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology enters into $50M at-the-market equity distribution agreement with Jefferies
--------------------------------------------------------------------------------

- Up to $50M of common stock may be sold from time to time in ATM offerings through Jefferies LLC.
- Jefferies receives 3% commission on gross proceeds; sales at prevailing market prices.
- Company has no obligation to sell any shares under the agreement.
- Shares offered under existing shelf registration statement (File No. 333-257687) effective July 13, 2021.
- Agreement may remain effective until July 2024 unless earlier terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774921025336/0001437749-21-025336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774921025336/pbyi20211104_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-025336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer